medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-1-63-67medsovet-11Research ArticleБРОНХОПУЛЬМОНОЛОГИЯ И ЛОРBRONCHIAL PULMONOLOGY AND ENTРациональная терапия ингаляционными кортикостероидами при бронхиальной астме у детейRational therapy of asthma in children with inhaled corticosteroidsГеппеН. А.GeppeN. A.noemail@neicon.ruКолосоваН. Г.KolosovaN. G.noemail@neicon.ruШаталинаС. И.ShatalinaS. I.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation201630122016116367Copyright © Геппе Н.А., Колосова Н.Г., Шаталина С.И., 20162016Геппе Н.А., Колосова Н.Г., Шаталина С.И.Geppe N.A., Kolosova N.G., Shatalina S.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/11

В настоящее время наиболее эффективными препаратами для лечения и достижения контроля над бронхиальной астмой (БА) являются ингаляционные глюкокортикостероиды (ИГКС), назначение которых, согласно международным рекомендациям, показано при персистирующей БА любой степени тяжести в качестве стартовой терапии [10].

Currently, the most effective drugs for the treatment and management of bronchial asthma (BA) are inhaled corticosteroids (ICS) which, according to global guidelines, are indicated as initial therapy for persistent asthma of any severity.

детибронхиальная астмаингаляционные глюкокортикостероидыбудесонидбудесонид/формотеролchildrenbronchial asthmainhaled corticosteroidsbudesonidebudesonide/formoterolReferencesГеппе Н.А., Шаталина С.И., Колосова Н.Г., Машукова Н.П, Малышев В.С. Комбинированный препарат будесонид/формотерол в контроле обострений бронхиальной астмы у детей. Доктор.ру. 2013, 3: 16-24.Геппе Н.А., Шаталина С.И., Колосова Н.Г., Машукова Н.П, Малышев В.С. Комбинированный препарат будесонид/формотерол в контроле обострений бронхиальной астмы у детей. Доктор.ру. 2013, 3: 16-24.Геппе Н.А., Бераиа Т.Т. Ингаляционные глюко-кортикостероиды в терапии бронхиальной астмы у детей. Cons. Med. Педиатрия. 2008. 1: 50-3.Геппе Н.А., Бераиа Т.Т. Ингаляционные глюко-кортикостероиды в терапии бронхиальной астмы у детей. Cons. Med. Педиатрия. 2008. 1: 50-3.Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». М., 2012, 180с.Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». М., 2012, 180с.AaLbers et aL. Protective effect of budesonide/ formoteroL compared with formoteroL, saLbuta-moL and pLacebo on repeated provocations with inhaLed AMP in patients with asthma: a randomised, doubLe-bLind, cross-over study. Respiratory Research. 2010, 11:66.AaLbers et aL. Protective effect of budesonide/ formoteroL compared with formoteroL, saLbuta-moL and pLacebo on repeated provocations with inhaLed AMP in patients with asthma: a randomised, doubLe-bLind, cross-over study. Respiratory Research. 2010, 11:66.Agertoft L, Pedersen S. Bone mineraL density in chiLdren with asthma receiving Long-term treatment with inhaLed budesonide. Am J Respir Crit Care Med. 1998. Jan. 157(1):178-83.Agertoft L, Pedersen S. Bone mineraL density in chiLdren with asthma receiving Long-term treatment with inhaLed budesonide. Am J Respir Crit Care Med. 1998. Jan. 157(1):178-83.Agertoft L, Pedersen S. Effect of Long-term treatment with inhaLed budesonide on aduLt height in chiLdren with asthma. N Engl J Med. 2000 Oct 12. 343(15):1064-9.Agertoft L, Pedersen S. Effect of Long-term treatment with inhaLed budesonide on aduLt height in chiLdren with asthma. N Engl J Med. 2000 Oct 12. 343(15):1064-9.Brattsand R et aL. The roLe of intraceLLuLar esterification in budesonide once-daiLy dosing and airway seLectivity. Clin. Ther. 2003. VoL. 25 SuppL. C.P. S28-41.Brattsand R et aL. The roLe of intraceLLuLar esterification in budesonide once-daiLy dosing and airway seLectivity. Clin. Ther. 2003. VoL. 25 SuppL. C.P. S28-41.Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, TownLey RG. Budesonide deLivered by TurbuhaLer is effective in a dose-dependent fashion when used in the treatment of aduLt patients with chronic asthma. J Allergy Clin Immunol. 1998 Apr. 101(4 Pt 1):457-63.Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, TownLey RG. Budesonide deLivered by TurbuhaLer is effective in a dose-dependent fashion when used in the treatment of aduLt patients with chronic asthma. J Allergy Clin Immunol. 1998 Apr. 101(4 Pt 1):457-63.Camargo CA et aL. Association between common asthma therapies and recurrent asthma exacerbations in chiLdren enroLLed in a state Medicaid pLan. Am J Health Syst Pharm. 2007 May 15;64(10):1054-61.Camargo CA et aL. Association between common asthma therapies and recurrent asthma exacerbations in chiLdren enroLLed in a state Medicaid pLan. Am J Health Syst Pharm. 2007 May 15;64(10):1054-61.GLobaL Strategy for Asthma Management and Prevention. GLobaL Initiative for Asthma (GINA); 2014. GLobaL Initiative for Asthma.http//www. ginasthma.orgGLobaL Strategy for Asthma Management and Prevention. GLobaL Initiative for Asthma (GINA); 2014. GLobaL Initiative for Asthma.http//www. ginasthma.orgHorvath G, Wanner A. InhaLed corticosteroids: effects on the airway vascuLature in bronchiaL asthma. Eur Respir J. 2006 Jan. 27(1):172-87.Horvath G, Wanner A. InhaLed corticosteroids: effects on the airway vascuLature in bronchiaL asthma. Eur Respir J. 2006 Jan. 27(1):172-87.MiLLer-Larsson A et aL. ProLonged Airway Activity and Improved SeLectivity of Budesonide PossibLy Due To Esterification. Am. J. Respir. Crit. Care Med. 2000. 162: 1455-1461.MiLLer-Larsson A et aL. ProLonged Airway Activity and Improved SeLectivity of Budesonide PossibLy Due To Esterification. Am. J. Respir. Crit. Care Med. 2000. 162: 1455-1461.PapadopouLos NG. et aL. InternationaL consensus on (ICON) pediatric asthma. Allergy, 2012. VoL. 67. 8: 976-997.PapadopouLos NG. et aL. InternationaL consensus on (ICON) pediatric asthma. Allergy, 2012. VoL. 67. 8: 976-997.Peter G. Gibson, NicoLas SaLtos, and K. Fakes Acute Anti-infLammatory Effects of InhaLed Budesonide in Asthma A Randomized ControLLed TriaL. Am J Respir Crit Care Med, 2001. 163: 32-36.Peter G. Gibson, NicoLas SaLtos, and K. Fakes Acute Anti-infLammatory Effects of InhaLed Budesonide in Asthma A Randomized ControLLed TriaL. Am J Respir Crit Care Med, 2001. 163: 32-36.TaL A et aL. Budesonide/formoteroL in a singLe inhaLer versus inhaLed corticosteroids aLone in the treatment of asthma. Pediatr Pulmonol. 2002 Nov. 34(5):342-50.TaL A et aL. Budesonide/formoteroL in a singLe inhaLer versus inhaLed corticosteroids aLone in the treatment of asthma. Pediatr Pulmonol. 2002 Nov. 34(5):342-50.Geppe N.A., Shatalina S.I., Kolosova N.G., Mashukova N.G., Malyshev V.S. Combination drug budesonide/formoterol in the management of bronchial asthma exacerbations in children. Doktor.Ru. 2013, 3: 16-24.Geppe N.A., Shatalina S.I., Kolosova N.G., Mashukova N.G., Malyshev V.S. Combination drug budesonide/formoterol in the management of bronchial asthma exacerbations in children. Doktor.Ru. 2013, 3: 16-24.Geppe N.A., Kolosova N.G., Denisova A.R. [et al]. The effectiveness of combination therapy of bronchial asthma in children in everyday outpatient practice. Meditsinskiy Sovet, 2014, 14: 50-56.Geppe N.A., Kolosova N.G., Denisova A.R. [et al]. The effectiveness of combination therapy of bronchial asthma in children in everyday outpatient practice. Meditsinskiy Sovet, 2014, 14: 50-56.National program "Bronchial asthma in children. Treatment strategy and prevention". М., 2012, 180 p.National program "Bronchial asthma in children. Treatment strategy and prevention". М., 2012, 180 p.

The authors declare that there are no conflicts of interest present.